Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain

Written by ClinicalTrials.gov

Category: Osteoporosis

Published: 26 October 2009

Condition: Back Pain
Interventions: Drug: REGN475/SAR164877; Drug: Placebo
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Terminated - verified August 2011

Details: Last Updated: 26 October 2009

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies